Cargando…

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study

BACKGROUND AND AIMS: The FDA-approved multitarget stool-DNA [mt-sDNA] test is a successful colorectal cancer [CRC] screening tool in average-risk individuals but is not indicated for patients with inflammatory bowel disease [IBD]. We determined the performance of the mt-sDNA assay without the haemog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itzkowitz, Steven, Farraye, Francis A, Limburg, Paul J, Gagrat, Zubin, Olson, Marilyn C, Zella, Julia, Kisiel, John B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588779/ https://www.ncbi.nlm.nih.gov/pubmed/37166153 http://dx.doi.org/10.1093/ecco-jcc/jjad069

Ejemplares similares

Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA
por: Ebner, Derek W., et al.
Publicado: (2021)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy
por: Eckmann, Jason D., et al.
Publicado: (2020)

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
por: Mahmoud, Remi, et al.
Publicado: (2018)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
por: Shah, Shailja C., et al.
Publicado: (2019)

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
por: Hashash, Jana G, et al.
Publicado: (2021)

Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing
por: Youssef, Omar, et al.
Publicado: (2017)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Inflammatory Bowel Disease Associated Colorectal Neoplasia
por: Vu, Michelle, et al.
Publicado: (2012)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Obesity Markers as Predictors for Colorectal Neoplasia
por: Kwon, Jin-Hyun, et al.
Publicado: (2017)

Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia
por: Aitchison, Alan, et al.
Publicado: (2022)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Stool-Based Tests for Colorectal Cancer Screening: Performance Benchmarks Lead to High Expected Efficacy
por: Ebner, Derek W., et al.
Publicado: (2020)

Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
por: Sauceda, Consuelo, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults
por: Weiser, Emily, et al.
Publicado: (2020)

Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
por: Dulai, Parambir S, et al.
Publicado: (2016)

Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia
por: Ballester, Veroushka, et al.
Publicado: (2020)

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
por: Mahmoud, Remi, et al.
Publicado: (2019)

An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis
por: Moktan, Varun P., et al.
Publicado: (2021)

Role of endoscopy in the surveillance and management of colorectal neoplasia in inflammatory bowel disease
por: Manchanda, Shaad, et al.
Publicado: (2019)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

The Presence of Gut Microbial Genes Encoding Bacterial Genotoxins or Pro-Inflammatory Factors in Stool Samples from Individuals with Colorectal Neoplasia
por: Gómez-Moreno, Ramón, et al.
Publicado: (2019)

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2023)

Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities
por: Redwood, Diana, et al.
Publicado: (2023)

Health Maintenance for Adult Patients with Inflammatory Bowel Disease
por: Hashash, Jana G., et al.
Publicado: (2021)

No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps
por: de Jong, Michiel E, et al.
Publicado: (2020)

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose‐effect relationship
por: Wijnands, Anouk M., et al.
Publicado: (2023)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer
por: ZHANG, YIBO, et al.
Publicado: (2015)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia
por: de Jong, Michiel E., et al.
Publicado: (2022)

Visceral Fat Area and Markers of Insulin Resistance in Relation to Colorectal Neoplasia
por: Yamamoto, Shuichiro, et al.
Publicado: (2010)

A systematic review of microbial markers for risk prediction of colorectal neoplasia
por: Yu, Lili, et al.
Publicado: (2022)

A207 CLONAL PATTERNS BETWEEN POUCH NEOPLASIA AND PRIOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN EXPLORATORY COHORT STUDY
por: Van Lierop, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fvdnjrd46gbov9i7o9vkrt2dli